News

Edgewise Therapeutics, Inc., a leading muscle disease biopharmaceutical company, unveiled positive results in its sevasemten programme for Becker and Duchenne muscular dystrophies. The company ...
EVA Pharma & Porton Advanced Solutions ink MoU to expand CAR T-cell therapy access in Middle East and Africa: Suzhou, Cairo Friday, June 27, 2025, 16:00 Hrs [IST] EVA Pharma, one ...
Theravance Biopharma announces Viatris receives China NMPA approval for Yupelri inhalation solution to treat COPD: Dublin Friday, June 27, 2025, 17:00 Hrs [IST] Theravance Biophar ...
Nethradhama and Sun Pharma launch cataract awareness to promote early diagnosis: Our Bureau, Bengaluru Friday, June 27, 2025, 17:15 Hrs [IST] Nethradhama Super Speciality Eye Hosp ...
Qure.ai recognized among TIME’s 100 Most Influential Companies of 2025: Our Bureau, Bengaluru Friday, June 27, 2025, 16:15 Hrs [IST] Qure.ai, the world’s most widely adopted d ...
ProFound Therapeutics enters multi-year strategic collaboration with Novartis to discover and develop novel therapeutics for cardiovascular disease: Cambridge, Massachusetts Frida ...
Gokula Education Foundation (Medical), that runs the Ramaiah Group of Medical & Healthcare Institutions including Ramaiah Memorial Hospital and other associated institutions has announced the ...
Telangana DCA sets new precedent with arrest of two wholesalers for selling counterfeit drugs: Peethaambaran Kunnathoor, Chennai Friday, June 27, 2025, 13:10 Hrs [IST] For the fir ...
Galderma begins 2 new clinical trials to investigate efficacy and safety of nemolizumab to treat patients with systemic sclerosis: Zug, Switzerland Friday, June 27, 2025, 13:00 Hr ...
Pfizer announces positive results from phase 3 BASIS study of Hympavzi in haemophilia A or B with inhibitors: New York Friday, June 27, 2025, 10:00 Hrs [IST] Pfizer Inc. announced ...
Recordati signs licensing agreement with Amarin to commercialize cardiovascular medicine, Vazkepa in Europe: Milan, Italy Friday, June 27, 2025, 11:00 Hrs [IST] Recordati, an inte ...